Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1995-05-25
1999-07-20
Railey, II, Johnny F.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
435 691, 4351723, A61K 4800, C12N 510
Patent
active
059253452
ABSTRACT:
A vector, in particular a retroviral vector, which includes a heterologous or foreign gene and a gene encoding a negative selective marker. The negative selective marker enables one to kill cells which contain the gene encoding the negative selective marker, when a particular agent is administered to such cells.
REFERENCES:
patent: 5358866 (1994-10-01), Mullen et al.
patent: 5359046 (1994-10-01), Capon et al.
patent: 5529774 (1996-06-01), Barba et al.
Hellerman, et al., Proc. Nat. Acad. Sci., vol. 81, pp. 5340-5344 (Sep. 1984).
Moolten, Cancer Research, vol. 46, pp. 5276-5281 (Oct. 1986).
Selden, et al., Science, vol. 236, pp. 714-718 (May 8, 1987).
Borelli, et al., Proc. Nat. Acad. Sci., vol. 85, pp. 7572-7576 (Oct. 1988).
Breakfield, Neurobiology of Aging, vol. 10, pp. 647-648 (1989).
Heyman, et al., Proc. Nat. Acad. Sci., vol. 86, pp. 2698-2702 (Apr. 1989).
Borelli, et al., Nature, vol. 339, pp. 538-541 (Jun. 15, 1989).
Moolten, et al., Human Gene Therapy, vol. 1, pp. 125-134 (1990).
Zwiebel, et al., Annals New York Academy of Sciences, vol. 618, pp. 394-404 (1990).
Moolten, et al., J. Nat. Cancer Inst., vol. 82, No. 4, pp. 297-300 (Feb. 21, 1990).
Gansbacher, et al., J. Cell Biochem., Supp. 15G, Abstract S218 (Apr. 6-Apr. 25, 1991).
Fleischman, Am. J. Med. Sci., vol. 301, No. 5, pp. 353-363 (1991).
Plautz, et al., The New Biologist, vol. 3, No. 7, pp. 709-715 (Jul. 1991).
Cardin et al., "Inhibition of lymphocyte proliferation by synthetic peptides homologous to human plasma apolipoproteins B and E", Bichem. Biophys. Res. Commun., 154(2): 741-745, (1988).
Jackson et al., "Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII", Proc. Nat. Acad. Sci. USA, 81: 2945-2949, (1984).
"Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy," Orkin and Motulsky, Co-chairs, Dec. 7, 1995.
Crystal, Science 270:404-410 (1995).
K.-i. Arai et al., Ann. Rev. Biochem. 59:783-836 (1990).
Gilboa et al., Trends in Genetics 10(4):139-144 (1994).
Daar et al., Proc. Natl. Acad. Sci. USA 87:6574-6578 (1990).
Johnston et al., Science 260:1286-1293 (1993).
Kay et al., Proc. Natl. Acad. Sci. USA 91:2353-2357 (1994).
Smith et al., Nature Genetics 5:397-402 (1993).
Lozier et al., JAMA 271(1):47-51 (1994).
Connelly et al., Human Gene Therapy 6:185-193 (1995).
Hoeben et al., Hum. Gene Ther. 4:179-186 (1993).
Coghlan, New Scientist 148:14-15 (1995).
Kozarsky et al., J. Biol. Chem. 269(18):13695-13702 (1994).
Kozarsky et al., Nature Genetics 13:54-62 (1996).
Fenjves et al., Human Gene Therapy 5:1241-1248 (1994).
Kashyap et al., J. Clinical Investigation 96:1612-1620 (1995).
Barinaga, Science 266:1326 (1994).
Kolata, "In the Rush Toward Gene Therapy, Some See a High Risk of Failure," The New York Times, Jul. 25, 1995, Sec. C3.
Blaese, Hospital Practice 30(12):37-45 (1995).
Anderson W. French
Blaese Michael
Chiang Yawen L.
Eglitis Martin
McLachlin Jeanne R.
Genetic Therapy, Inc.
Lillie Raymond J.
Olstein Elliot M.
Railey II Johnny F.
The United States of America as represented by the Department of
LandOfFree
Vectors including foreign genes and negative selective markers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vectors including foreign genes and negative selective markers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors including foreign genes and negative selective markers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1319893